ALNY vs BAC · P/E 76, rev $1.29B vs P/E 13, rev $31.56B
Alnylam Pharmaceuticals Inc (ALNY) versus Bank of America Corp (BAC) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Bank of America Corp (BAC) is a banks - diversified company listed on US. It is led by Brian Moynihan.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported BAC revenue for 2026-06-30 was $31.56B. Net income was $9.07B. Revenue was up 4.2% from 2026-03-31 to 2026-06-30. BAC currently screens at market cap $382.01B and trailing P/E 13.4.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. BAC currently screens at market cap $382.01B and trailing P/E 13.4.
Not investment advice. Open the ALNY and BAC stock pages for the full models.
Not investment advice.